Perseus Proteomics Inc. (TYO:4882)
Japan · Delayed Price · Currency is JPY 141.00
-4.00 (-2.76%)
Aug 19, 2026, 3:30 PM JST
Perseus Proteomics Market Cap
Perseus Proteomics has a market cap or net worth of 2.67 billion as of August 19, 2026. Its market cap has decreased by -48.24% in one year.
Market Cap
2.67B
Enterprise Value
1.08B
Revenue
147.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
141.00
ChartMarket Cap Chart
Since June 22, 2021, Perseus Proteomics's market cap has decreased from 10.12B to 2.67B, a decrease of -73.60%. That is a compound annual growth rate of -22.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 2.67B | -19.12% |
| Dec 30, 2025 | 3.30B | -60.12% |
| Dec 30, 2024 | 8.28B | 13.70% |
| Dec 29, 2023 | 7.29B | 97.33% |
| Dec 30, 2022 | 3.69B | -20.91% |
| Dec 30, 2021 | 4.67B | -53.87% |
| Jun 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.29T |
| Otsuka Holdings | 6.31T |
| Daiichi Sankyo Company | 4.84T |
| Astellas Pharma | 4.09T |
| Kyowa Kirin | 1.33T |
| Ono Pharmaceutical | 1.13T |
| Santen Pharmaceutical | 610.10B |
| JCR Pharmaceuticals | 60.77B |